BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
IGF1
,
Metabolism of xenobiotics
,
Obesity
,
Embryo
,
Anticancer prodrugs
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptors thrombopoietin
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Structure of the thrombopoietin-MPL receptor complex is a blueprint for biasing hematopoiesis.
Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabol…
Erythropoietin receptor contributes to thrombopoietin receptor (Mpl)-independent thrombocytopoiesis …
Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists.
TPO-RAs and ITP remission: cause or coincidence?
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP
SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due T…
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving C…
A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patie…
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thr…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ